RNC-OB Practice Questions

The Bishop score provides an objective assessment of cervical readiness, which directly correlates with the duration of labor and the probability of achieving a successful vaginal birth following induction. According to American College of Obstetricians and Gynecologists guidelines, a Bishop score of six or less denotes an unfavorable or unripe cervix. Initiating labor induction with oxytocin alone in the presence of an unfavorable cervix substantially increases the risk of prolonged labor, failed induction, and cesarean delivery. Therefore, a score of six or less indicates the need for pre-induction cervical ripening utilizing mechanical methods, such as a transcervical Foley catheter, or pharmacological agents, such as dinoprostone or misoprostol. Conversely, a score of seven to eight reflects an intermediate degree of favorability where ripening may not be necessary depending on parity and clinical context. A score of nine or greater indicates a highly favorable cervix, signifying that spontaneous labor is imminent or that induction with oxytocin alone is associated with vaginal delivery rates comparable to spontaneous labor.

Patients with prolonged vomiting from hyperemesis gravidarum are at extreme risk for severe micronutrient depletion, particularly thiamine (vitamin B1), whose stores can be depleted within several weeks. Administering dextrose without prior thiamine supplementation drives rapid carbohydrate metabolism, which consumes remaining thiamine cofactors and precipitates acute Wernicke encephalopathy. This severe neurological condition is characterized by the classic triad of ataxia, ocular dysfunction, and altered mental status. Therefore, intravenous thiamine to prevent acute neurological complications must always precede any glucose infusion. In contrast, intravenous pyridoxine to manage persistent nausea symptoms is a safe antiemetic frequently used in pregnancy, but it does not prevent or treat acute carbohydrate-induced neurotoxicity. Similarly, intravenous magnesium to prevent maternal cardiac dysrhythmias may be necessary if severe hypomagnesemia is documented, but magnesium is not the critical cofactor required to prevent dextrose-triggered encephalopathy. Ensuring prompt thiamine administration before starting dextrose-containing fluids is a vital inpatient nursing intervention that safeguards against permanent brain damage or maternal death.

The three-tier fetal heart rate interpretation system categorizes intrapartum tracings based on their predictive value regarding fetal acid-base balance. A Category II tracing is defined as an indeterminate tracing not classified as Category I or Category III. Category II tracings are not predictive of abnormal fetal acid-base status, but they also lack the positive predictive value of a normal tracing, requiring continued fetal evaluation, in-utero resuscitation, and ongoing clinical reassessment. In contrast, an abnormal tracing highly predictive of abnormal fetal acid-base status describes a Category III tracing, which includes a sinusoidal pattern or absent baseline variability accompanied by recurrent late decelerations, recurrent variable decelerations, or bradycardia, mandating immediate intervention. A normal tracing highly predictive of normal fetal acid-base status describes Category I, which requires a normal baseline rate, moderate baseline variability, and the absence of late or variable decelerations. Recognizing that Category II encompasses all intermediate patterns allows the obstetrical nurse to implement targeted intrauterine interventions while monitoring for pattern improvement or deterioration.

Obstetrical lacerations are classified into four distinct anatomical tiers based on the depth of tissue disruption. A second-degree perineal laceration extends beyond the perineal skin and vaginal epithelium to involve the underlying perineal body fascia and musculature, including the bulbocavernosus and superficial transverse perineal muscles, while leaving the anal sphincter complex completely intact. Repair involves surgical reapproximation of the muscular layer to restore pelvic floor integrity and support. In contrast, tearing limited to the vaginal mucosa and superficial perineal skin only constitutes a first-degree laceration; these superficial injuries frequently do not require suturing unless active hemostasis is needed. An injury extending into the external anal sphincter involving partial muscle thickness defines a third-degree laceration (specifically a grade 3A tear if under fifty percent thickness, or 3B if over fifty percent). Third-degree tears require specialized surgical repair to prevent long-term fecal incontinence and pelvic floor dysfunction. Fourth-degree lacerations extend entirely through the anal sphincter and into the rectal mucosa.

The American Society of Regional Anesthesia and Pain Medicine (ASRA) and the American College of Obstetricians and Gynecologists recommend specific withholding intervals for anticoagulants to minimize the catastrophic risk of spinal or epidural hematoma. For patients receiving therapeutic low-molecular-weight heparin (such as enoxaparin 1 mg/kg twice daily or 1.5 mg/kg daily), a minimum interval of at least twenty-four hours after medication administration is required before performing any neuraxial anesthetic procedure or catheter manipulation. In contrast, at least twelve hours after medication administration is the established safety window for prophylactic low-molecular-weight heparin dosing (such as enoxaparin 40 mg once daily), which carries a lower anticoagulant burden and faster clearance. Selecting at least six hours after medication administration is profoundly unsafe and represents a critical violation of anesthesia safety protocols, placing the patient at severe risk for compressive spinal hematoma leading to permanent lower-extremity paralysis. Careful review of medication administration records and exact dosing regimens is an essential obstetric nursing responsibility prior to epidural placement.

During normal pregnancy, plasma fibrinogen levels rise significantly as part of a hypercoagulable state, typically ranging between 400 and 600 mg/dL in the third trimester. Because of this physiological increase, a fibrinogen level falling below 200 mg/dL is abnormal and serves as a sensitive indicator of consumptive coagulopathy and active disseminated intravascular coagulation. In this pathological process, widespread microvascular thrombi rapidly consume clotting factors and platelets, leading to secondary fibrinolysis and severe maternal hemorrhage. A plasma fibrinogen level between 300 and 400 mg/dL is incorrect because, while on the lower end of normal for late pregnancy, it does not confirm acute consumption or meet the threshold for active coagulopathy. A plasma fibrinogen level above 500 mg/dL is incorrect because this represents normal physiologic pregnancy-induced hyperfibrinogenemia, demonstrating that clotting substrate reserves remain intact. In an obstetric emergency, a declining fibrinogen level below 200 mg/dL warrants immediate intervention, including volume replacement, blood product resuscitation with cryoprecipitate, and correction of the underlying etiology.

Proper cup placement is the single most critical factor for successful vacuum-assisted vaginal delivery and the prevention of maternal-fetal trauma. The vacuum extractor cup must be positioned precisely over the fetal flexion point, which is located on the sagittal suture approximately three centimeters anterior to the posterior fontanelle (and roughly six centimeters posterior to the anterior fontanelle). Placing the cup at this anatomical landmark promotes optimal fetal head flexion, keeps the presenting suboccipitobregmatic diameter as small as possible, and aligns traction along the pelvic curve of Carus. Placing the cup directly centered over the anterior fontanelle along the sagittal suture causes deflexion of the fetal vertex, converting the presenting diameter to a larger, unfavorable dimension and increasing traction resistance and failure rates. Placing the cup directly centered over the posterior fontanelle along the lambdoid suture risks scalp trauma, subgaleal hematoma, and asymmetrical traction. Accurate cup placement minimizes cup detachments (pop-offs) and intracranial shear stresses, ensuring maternal and neonatal safety during operative birth.

According to the National Institute of Child Health and Human Development (NICHD) fetal monitoring guidelines, baseline fetal heart rate must be determined over a minimum evaluation period of ten minutes, excluding accelerations, decelerations, and periods of marked variability. Baseline fetal tachycardia is formally defined as a baseline heart rate exceeding 160 beats per minute sustained for at least ten minutes. A rate exceeding 150 beats per minute for five minutes is incorrect because 150 beats per minute falls within the normal physiological baseline range of 110 to 160 beats per minute, and five minutes is insufficient to establish a true baseline change. A rate exceeding 170 beats per minute for fifteen minutes is also tachycardic, but setting the diagnostic threshold at 170 beats per minute would miss tachycardia that begins above 160 beats per minute. Common etiologies of fetal tachycardia include maternal intra-amniotic infection, maternal pyrexia, fetal anemia, dehydration, or beta-mimetic tocolytic therapy. Recognizing a baseline exceeding 160 beats per minute for ten minutes prompts timely clinical evaluation and targeted maternal-fetal intervention.

The established therapeutic serum magnesium concentration required to achieve effective seizure prophylaxis in patients with severe preeclampsia or eclampsia is 4.8 to 8.4 mg/dL, which corresponds to 4.0 to 7.0 mEq/L. Maintaining maternal serum magnesium levels within this target therapeutic window stabilizes neuronal membranes, decreases motor end-plate acetylcholine release, and prevents cerebral convulsions without causing toxic maternal neuromuscular depression. A range of 2.0 to 4.0 mg/dL (1.7 to 3.3 mEq/L) is incorrect because normal physiological baseline serum magnesium in pregnancy is approximately 1.5 to 2.5 mg/dL; levels under 4.8 mg/dL fall below the commonly cited therapeutic range. Conversely, a concentration of 9.0 to 12.0 mg/dL (7.5 to 10.0 mEq/L) is incorrect because it represents dangerous hypermagnesemia, where deep tendon reflexes are lost and respiratory depression can follow as the level rises. Frequent maternal bedside assessments of patellar reflexes, respiratory rate, and hourly urine output help detect magnesium toxicity early.

In a well-flexed vertex presentation, the fetal chin rests firmly on the sternum, presenting the suboccipitobregmatic diameter to the maternal birth canal. This diameter extends from the undersurface of the occiput to the center of the anterior fontanel (bregma) and measures approximately 9.5 centimeters, providing the optimal and smallest anteroposterior cephalic dimension for pelvic descent. The occipitofrontal diameter measures approximately 11.5 centimeters and is the presenting anteroposterior diameter in a partially flexed or military cephalic attitude. The submentobregmatic diameter also measures approximately 9.5 centimeters, but it presents when the fetal head is fully extended in a face presentation rather than a flexed cephalic presentation.

According to the American College of Obstetricians and Gynecologists (ACOG), postpartum hemorrhage is defined as cumulative blood loss of at least 1,000 milliliters or blood loss accompanied by signs or symptoms of hypovolemia within 24 hours following birth, regardless of the route of delivery. Historically, postpartum hemorrhage was categorized by volume thresholds of greater than 500 milliliters for vaginal births and greater than 1,000 milliliters for cesarean births. However, clinical studies demonstrated that typical blood loss during uncomplicated vaginal deliveries frequently approaches 500 milliliters without adverse maternal outcomes, rendering the old cutoff overly sensitive and non-specific. Blood loss exceeding 500 milliliters following an uncomplicated vaginal delivery is therefore an outdated threshold and no longer triggers the diagnostic definition of postpartum hemorrhage in contemporary practice. Relying on laboratory confirmation showing a 10 percent drop from baseline hematocrit represents an obsolete criterion that provides retrospective confirmation rather than timely, actionable guidance during an acute clinical crisis. Immediate identification of cumulative volume loss or hypovolemic signs enables rapid resuscitation and prevents severe maternal morbidity.

Intravenous labetalol is a nonselective beta-blocker with alpha-1 blocking activity. Because of its beta-blocking properties, it can trigger bronchospasm by blocking beta-2 receptors in the bronchial smooth muscle; therefore, it is contraindicated in patients with asthma, uncompensated heart failure, or severe bradycardia. In these clinical scenarios, intravenous hydralazine or oral immediate-release nifedipine should be selected instead. A baseline fetal heart rate tachycardia is not a contraindication to labetalol; in fact, maternal beta-blocker therapy can occasionally lower maternal and fetal heart rates, but it is not withheld for preexisting fetal tachycardia. Persistent nonproteinuric gestational hypertension describes a hypertensive disorder that may indeed require pharmacologic treatment if pressures reach the severe range, making it an indication rather than a contraindication. Understanding these distinct pharmacologic properties ensures safe selection among first-line agents during acute hypertensive crises in obstetrics.

The correct choice is pain exacerbation when assuming an upright posture. Post-dural puncture headache (PDPH) occurs when an accidental dural puncture during neuraxial anesthesia or analgesia results in continuous leakage of cerebrospinal fluid into the epidural space. This fluid depletion decreases intracranial pressure and reduces buoyancy, causing the brain to sag caudalward and stretch pain-sensitive meninges, bridging veins, and cranial nerves. The hallmark clinical sign of PDPH is a postural or orthostatic headache: it develops or drastically worsens within seconds to minutes of sitting or standing upright and is significantly relieved or completely abolished when assuming a supine or recumbent position. In contrast, continuous throbbing unaffected by changes in position points away from post-dural puncture headache and toward other causes, such as migraine or a hypertensive disorder like preeclampsia. Marked symptom relief upon standing and walking contradicts the fundamental pathophysiology of intracranial hypotension, where gravitational dependent positioning intensifies downward mechanical traction on sensory structures, making upright posture intolerable for patients suffering from true post-dural puncture headache.

Umbilical cord blood gas analysis distinguishes between metabolic, respiratory, and mixed acidemia to determine the etiology and timing of fetal compromise. Normal carbon dioxide with elevated base deficit characterizes pure metabolic acidemia. In metabolic acidemia, prolonged or profound tissue hypoxia forces anaerobic cellular metabolism, producing lactic acid. Bicarbonate buffers the lactic acid, which consumes buffer reserves and creates a base deficit of 12 mmol/L or greater while respiratory carbon dioxide levels remain normal. Conversely, elevated carbon dioxide with normal base deficit characterizes pure respiratory acidemia. Respiratory acidemia occurs when sudden, acute impairment of fetal-maternal gas exchange, such as acute umbilical cord compression, prevents carbon dioxide elimination through the placenta without causing prolonged cellular hypoxia or lactic acid accumulation. Elevated carbon dioxide with elevated base deficit reflects mixed acidemia, which develops when prolonged respiratory compromise progresses to anaerobic metabolism and systemic lactic acidosis. Correctly differentiating pure metabolic acidemia provides vital insight into intrapartum hypoxic events and neonatal encephalopathy risks.

Contemporary obstetric practice and consensus guidelines from the American College of Obstetricians and Gynecologists define the onset of the active phase of the first stage of labor at 6 cm dilation. Landmark studies evaluating contemporary labor patterns demonstrated that cervical dilation accelerates more slowly before 6 cm and that labor progression typically speeds up markedly only after 6 cm is attained. Defining the active phase at 4 cm dilation reflects historical labor curves that frequently led to premature diagnoses of labor arrest and unnecessary primary cesarean births. Defining the onset of the active phase at 8 cm dilation is incorrect because this advanced dilation represents the transition phase rather than the entry point into active labor. Recognizing 6 cm as the threshold helps prevent premature interventions during normal latent labor.

The asymmetric tonic neck reflex, colloquially called the fencing reflex, is a primitive postural reflex present in full-term neonates that typically integrates by four to six months of age. When the infant is placed supine and the head is turned gently to one side, an intact reflex produces ipsilateral extension of the upper and lower extremities on the side toward which the face is rotated, paired with contralateral flexion of the opposite extremities. Consequently, rotating the head to the right induces extension of right-sided limbs and left-sided flexion. Flexion of right-sided limbs and left-sided extension represents the exact inverse of normal reflex physiology and indicates an abnormal motor finding. Bilateral abduction followed by adduction of the extremities describes the classic motor pattern of the Moro reflex, which is elicited by a sudden loss of support or vestibular perturbation rather than cervical rotation. Evaluating primitive neonatal reflexes allows clinicians to assess central nervous system maturation, peripheral neuromuscular integrity, and upper extremity symmetry.

Standard obstetric guidelines recommend that every unsensitized Rh D-negative pregnant patient receive an intramuscular dose of 300 micrograms of Rh immune globulin at 28 weeks of gestation. This proactive timing specifically targets the third trimester, during which asymptomatic transplacental fetomaternal hemorrhage occurs with increasing frequency as the placenta matures and thins. Administering prophylaxis at 28 weeks of gestation provides passive antibody coverage that persists for approximately twelve weeks, protecting the mother through the remainder of pregnancy and birth against alloimmunization from an Rh-positive fetus. Administering the routine dose at 24 weeks of gestation is premature because circulating antibody titers will decline before term delivery, leaving the patient unprotected during late gestation unless additional unscheduled doses are given. Conversely, waiting until 34 weeks of gestation leaves the patient vulnerable to alloimmunization during the critical weeks of the early third trimester when microhemorrhages commonly initiate maternal antibody formation. An indirect Coombs test is verified prior to administration at 28 weeks to ensure the patient has not already formed active anti-D antibodies.

Palpating the anterior fontanelle, orbital ridges, and root of the nose indicates a brow presentation, in which the head lies midway between flexion and full extension. The presenting diameter is the verticomental, running from the vertex to the chin and measuring about 13.5 centimeters, the largest anteroposterior diameter of the fetal head. Because it exceeds the dimensions of the average pelvis, a persistent brow presentation in a term fetus of normal size usually cannot deliver vaginally, which explains the poor progress despite adequate contractions. Many brows convert to a vertex or face presentation as labor continues, but a persistent brow generally leads to cesarean birth. The occipitofrontal diameter of about 11.5 centimeters presents when the head is in a military, partly deflexed attitude, as often seen with occiput posterior positions, and the examiner would feel sutures and fontanelles rather than facial landmarks. The submentobregmatic diameter of about 9.5 centimeters presents in a face presentation with full extension, where the chin, mouth, and nose are palpable. The nurse should anticipate a prolonged labor, monitor closely for arrest, and prepare for possible cesarean birth.

A contraction stress test assesses placental respiratory reserve by observing fetal heart rate responses to transient hypoxia induced by uterine contractions. A negative contraction stress test indicates fetal well-being and is defined by the absence of late or significant variable decelerations in the presence of adequate uterine contractions, which requires at least three contractions of 40 seconds duration within a 10-minute window. A negative CST strongly correlates with fetal survival and placental adequacy for at least one week following testing. Occurrence of late decelerations with intermittent contractions does not represent a negative test; depending on the exact pattern, late decelerations occurring with fewer than half of contractions indicate a suspicious or equivocal test, whereas persistent late decelerations indicate a positive test. Presence of variable decelerations with spontaneous contractions characterizes a suspicious or equivocal result indicating umbilical cord compression rather than a normal, reassuring assessment. The absence of decelerations remains the hallmark of a reassuring, negative contraction stress test.

In the two-step screening approach for gestational diabetes mellitus, a 50-gram nonfasting oral glucose challenge test is administered between 24 and 28 weeks of gestation. A blood glucose value of 140 mg/dL or higher (or 130 to 135 mg/dL depending on institutional protocol) is abnormal and warrants a follow-up diagnostic 100-gram 3-hour oral glucose tolerance test. A blood glucose value of 120 mg/dL or higher is within the expected normal physiological response post-challenge and does not necessitate further diagnostic testing. Conversely, while a blood glucose value of 180 mg/dL or higher is markedly elevated, selecting 180 mg/dL as the minimum screening threshold would miss a significant proportion of women with gestational diabetes due to excessive false negatives. Furthermore, a nonfasting glucose level of 200 mg/dL or greater typically allows for the direct diagnosis of gestational diabetes without completing a 3-hour diagnostic test. Therefore, 140 mg/dL remains the standard screening threshold to identify patients who require full 3-hour diagnostic evaluation.

Fetal malpresentation accounts for a notable proportion of cesarean deliveries, and accurate classification of breech subtypes is essential for intrapartum management. A complete breech presentation, also termed a full breech, occurs when both the fetal hips and both the fetal knees are fully flexed. In this posture, the fetal buttocks and feet present together at the maternal pelvic inlet, creating a compact presentation that resembles a cross-legged sitting posture. In contrast, the option describing flexion of hips with extended knees characterizes a frank breech presentation, which is the most common breech variation where the thighs lie against the abdomen and the feet lie alongside the head. The option describing extension of both hips and knees characterizes a footling or incomplete breech presentation, where one or both feet or knees descend through the cervix below the buttocks. Differentiating these variations is clinically relevant because complete and footling breech presentations carry a significantly higher risk of umbilical cord prolapse compared to frank breech, necessitating precise physical assessment and sonographic confirmation.

Caput succedaneum represents localized edema of the newborn scalp caused by mechanical compression against the cervix during labor. This serosanguineous subcutaneous fluid collection lies above the periosteum, which enables it to cross cranial suture lines freely. It is present at birth, feels soft and compressible, and typically resolves spontaneously within a few days without specific medical intervention or long-term sequelae. In contrast, a cephalohematoma involves subperiosteal hemorrhage resulting from ruptured blood vessels between the skull bone and the pericranium. Because the bleeding is confined beneath the periosteal layer, a cephalohematoma cannot cross cranial suture lines and frequently takes several weeks to resolve fully. Furthermore, a subgaleal hemorrhage involves bleeding into the loose connective tissue of the subaponeurotic space, which crosses suture lines and fontanels, extending into the neck and orbit; this represents a life-threatening emergency causing massive hypovolemia. Distinguishing between benign serosanguineous edema crossing suture margins and deeper hemorrhages is essential for prioritizing neonatal surveillance, initiating timely diagnostic imaging, and preventing severe neonatal hypovolemic shock or profound hyperbilirubinemia.

Closed-loop communication is an evidence-based patient safety practice requiring the receiver of a verbal order to repeat the directive verbatim back to the sender before execution. This verbal confirmation allows the sender to verify that the message was received accurately, correctly understood, and interpreted without miscommunication. In high-stress obstetric emergencies such as shoulder dystocia, verbal orders for maneuvers or medications are delivered rapidly, significantly increasing the potential for cognitive errors and misheard instructions. Merely acknowledging an urgent order with a rapid head nod or nonverbal gesture is insufficient because it provides no confirmation of precise understanding and fails to close the communication loop. Similarly, deferring immediate verbal verification to document the directive in the medical record delays urgent interventions and misses the opportunity for real-time error interception. Repeating the verbal order aloud ensures complete mutual understanding between healthcare team members, fosters psychological safety, and actively prevents adverse clinical outcomes stemming from misinterpreted drug dosages, conflicting instructions, or incorrectly executed obstetrical maneuvers during acute delivery room maternal-fetal emergencies.

In the two-step approach, the 1-hour 50 g glucose challenge is a screening test that does not require fasting. A value above the chosen cutoff, here 140 mg/dL, is abnormal and must be followed by the diagnostic fasting 100 g, 3-hour oral glucose tolerance test. Gestational diabetes is diagnosed only when two or more of the four 3-hour values meet or exceed the thresholds, commonly the Carpenter-Coustan or National Diabetes Data Group criteria. Diagnosing gestational diabetes and beginning nutrition therapy now skips the diagnostic step; many patients with an abnormal screen have a normal 3-hour test, and labeling them would bring unnecessary treatment, testing, and anxiety. Repeating the same 50 g screening test at 32 weeks delays diagnosis past the window when treatment most improves outcomes such as macrosomia, shoulder dystocia, and hypertensive disorders, and a repeat screen cannot answer the question an abnormal screen raises. The nurse should explain that the 3-hour test requires an overnight fast of at least 8 hours, an unrestricted diet with adequate carbohydrate in the preceding days, and remaining seated without smoking during the test.

Sudden lengthening of the protruding umbilical cord segment is a classic sign of placental detachment. As the placenta separates from the decidua basalis and descends into the lower uterine segment or vagina, the cord lengthens noticeably, the uterus rises in the abdomen and assumes a globular shape, and a sudden gush of blood typically appears. Gradual softening and flattening of the uterine fundus is incorrect because the uterus contracts firmly, becoming globular, firm, and elevated rather than soft or flat; a boggy or softening fundus suggests uterine atony rather than separation. Continuous steady trickle of bright red amniotic fluid is incorrect because the fluid released upon separation is dark or bright maternal blood rather than amniotic fluid, and separation typically causes an abrupt gush rather than an ongoing slow trickle. Pulling on the umbilical cord before these definitive signs occur risks uterine inversion, cord avulsion, and excessive maternal hemorrhage.

Montevideo units quantify uterine contraction performance using an intrauterine pressure catheter by calculating the sum of peak contraction pressures above resting tone across a 10-minute period. Generation of 200 or more Montevideo units indicates adequate uterine contractility sufficient to produce progressive cervical dilation and effacement during the active phase of labor. Obstetric clinical guidelines establish that an arrest of labor cannot be diagnosed until a patient has reached at least six centimeters dilation and maintained a uterine contraction pattern of at least 200 Montevideo units for at least four hours without cervical change, or at least six hours of inadequate contractions with oxytocin. Generation of 100 to 140 Montevideo units represents inadequate or hypocontractile uterine activity that is insufficient to achieve normal labor progress, often requiring oxytocin augmentation. Generation of 150 to 190 Montevideo units is borderline and frequently fails to generate consistent cervical change. Reaching 200 Montevideo units is the accepted benchmark for adequate contractions, but it does not guarantee cervical change.

First-line intrapartum antibiotic treatment for suspected intraamniotic infection (chorioamnionitis) consists of intravenous ampicillin and gentamicin. This broad-spectrum combination effectively targets the polymicrobial ascending pathogens typically responsible for intraamniotic infection, including Group B Streptococcus, Escherichia coli, and other enteric Gram-negative organisms. In patients undergoing cesarean delivery, anaerobic coverage such as clindamycin or metronidazole is added. Intravenous cefazolin combined with oral azithromycin does not provide sufficient broad-spectrum coverage for intraamniotic infection; cefazolin is primarily utilized for surgical site prophylaxis, and oral azithromycin is reserved for adjunctive cesarean prophylaxis or conditions like chlamydia and preterm premature rupture of membranes. Intravenous vancomycin combined with intravenous metronidazole is inappropriate as initial empiric therapy because vancomycin is restricted to severe penicillin-allergic patients with documented high risk for anaphylaxis, and metronidazole alone lacks adequate coverage against common Gram-negative aerobic pathogens unless combined with an aminoglycoside. Prompt administration of intravenous ampicillin and gentamicin significantly reduces both maternal postpartum endometritis and neonatal bacteremia.

Documented group B streptococcal bacteriuria at any colony count during the current pregnancy signifies high maternal bacterial load and heavy genital tract colonization. According to American College of Obstetricians and Gynecologists guidelines, these patients have an established indication for intrapartum antibiotic prophylaxis during labor or following prelabor rupture of membranes. Consequently, administering intrapartum antibiotics without third-trimester screening is the correct clinical management plan, as repeating screening cultures is clinically unnecessary and cannot overturn the established indication. In contrast, obtaining repeat cultures at thirty-six weeks gestation is inappropriate because maternal colonization status is already defined, rendering further late-pregnancy screening redundant. Likewise, treating with antibiotics only if cultures remain positive is unsafe and incorrect because a negative follow-up urine or rectovaginal culture does not eliminate the persistent risk of neonatal early-onset sepsis. Intrapartum antibiotic prophylaxis remains strictly indicated regardless of whether the antepartum bacteriuria was treated and resolved. Withholding intrapartum prophylaxis based on subsequent culture results compromises newborn safety.

Carboprost tromethamine is an injectable synthetic prostaglandin F2-alpha analogue used to manage refractory postpartum hemorrhage due to uterine atony. Prostaglandin F2-alpha stimulates smooth muscle contraction throughout the body, including bronchial smooth muscle. Consequently, active asthma is a strict contraindication because carboprost can precipitate intense, life-threatening bronchoconstriction and respiratory failure. Chronic hypertension is a contraindication to methylergonovine maleate due to peripheral vasoconstrictive properties, but it is not a contraindication to carboprost, although transient blood pressure elevations can occasionally occur. Gestational diabetes is not a contraindication to carboprost, as the drug does not adversely alter acute glycemic stability or insulin requirements. Reviewing maternal medical history prior to administering second-line uterotonics prevents severe drug-induced complications.

Subcutaneous terbutaline 0.25 milligrams is the standard tocolytic regimen administered prior to external cephalic version (ECV) to achieve temporary uterine relaxation. By binding to beta-2 adrenergic receptors in myometrial tissue, terbutaline inhibits contractions and relaxes the uterine musculature, which significantly enhances the clinician's ability to manipulate the fetus externally into a cephalic presentation and increases overall procedure success. Intramuscular magnesium sulfate 4 grams is incorrect because magnesium sulfate is primarily utilized for fetal neuroprotection or maternal seizure prophylaxis in preeclampsia; it is not the preferred rapid-acting agent for acute procedural tocolysis during ECV. Intravenous nitroglycerin 0.4 milligrams provides profound uterine relaxation but is reserved for acute intrapartum emergencies such as retained placenta or uterine inversion due to its substantial risk of maternal hypotension and cardiovascular instability.

The Rosette screening test is a qualitative assay used to identify whether fetal red blood cells have entered the maternal bloodstream following delivery or trauma in Rh-negative mothers. The test uses anti-D antibodies that bind to Rh-positive fetal erythrocytes, which then bind indicator cells to form visible clusters resembling rosettes. A positive Rosette test confirms fetomaternal hemorrhage exceeding typical baseline amounts and indicates the urgent need for quantitative testing, such as a Kleihauer-Betke acid elution test or flow cytometry, to calculate the exact dosage of Rh immune globulin required. Circulating maternal anti-D immunoglobulin levels in blood are evaluated via an indirect Coombs test, not a Rosette test, to detect maternal sensitization. Maternal antibodies coating fetal erythrocytes in cord are detected using a direct Coombs test performed on infant cord blood, rather than maternal circulation. Because the Rosette assay only provides qualitative presence or absence of D-positive fetal cells in maternal blood, it serves purely as an initial screen for substantial fetomaternal hemorrhage. Consequently, identifying fetal red blood cells in maternal circulation remains its distinct diagnostic function.

A pudendal nerve block is a localized regional anesthesia technique frequently utilized during the second stage of labor, operative vaginal deliveries, or extensive perineal laceration repairs. The pudendal nerve originates from the anterior divisions of the sacral plexus, specifically incorporating the S2, S3, and S4 spinal nerve roots. Transvaginal injection of local anesthetic near the ischial spines successfully blocks these fibers, achieving targeted somatic sensory blockade of the perineum, vulva, and lower third of the vagina. In contrast, uterine fundal and cervical sensory pathways travel through visceral afferent fibers entering the spinal cord at T10 through L1; therefore, the option targeting the fundus and cervix via roots T10 through L1 describes the sensory distribution addressed by neuraxial analgesia during the first stage of labor rather than a pudendal block. Similarly, the option involving the upper vagina and bladder via roots L2 through L4 is incorrect because these somatic and visceral dermatomes are not innervated by the pudendal nerve, and a pudendal block does not relieve contraction-related pain.

Under the Carpenter-Coustan diagnostic criteria for gestational diabetes mellitus, a plasma glucose concentration of 140 mg/dL represents the minimum threshold for an abnormal result at the 3-hour mark of a 100-gram oral glucose tolerance test. When completing the standard 3-hour diagnostic protocol, plasma glucose measurements are drawn fasting and at 1, 2, and 3 hours following consumption of the 100-gram oral glucose load; the diagnostic cutoff values are 95 mg/dL, 180 mg/dL, 155 mg/dL, and 140 mg/dL, respectively. A plasma glucose concentration of 130 mg/dL is incorrect because it falls below the diagnostic cutoff for the third hour, representing a normal value that does not contribute toward a diagnosis of gestational diabetes. A plasma glucose concentration of 155 mg/dL is incorrect for this specific interval because 155 mg/dL serves as the diagnostic threshold for the 2-hour measurement rather than the 3-hour measurement. Two or more abnormal values across the four draws are required to formally establish the diagnosis of gestational diabetes, making familiarity with the specific hourly cutoffs clinically essential.

Local anesthetic systemic toxicity is a life-threatening complication that can develop rapidly if an epidural catheter is inadvertently placed into an epidural vein, leading to rapid systemic absorption of amide local anesthetics such as bupivacaine or ropivacaine. The definitive and specific pharmacological antidote for local anesthetic systemic toxicity is intravenous lipid emulsion twenty percent. Lipid emulsion acts as a lipid sink, sequestering lipophilic local anesthetic molecules away from myocardial and cerebral tissues, while concurrently restoring intracellular metabolic energy and accelerating drug clearance. In contrast, intravenous calcium chloride ten percent is indicated for treating symptomatic hypocalcemia or severe hyperkalemia with cardiac instability, but it does not reverse the myocardial sodium channel blockade or cellular toxicity caused by local anesthetics. Intravenous sodium bicarbonate eight percent is employed to alkalinize urine or manage specific intoxications, such as tricyclic antidepressant overdose, but it lacks efficacy as the primary antidote for local anesthetic systemic toxicity. When toxicity occurs, prompt cessation of the local anesthetic, airway stabilization, and early administration of intravenous lipid emulsion are vital life-saving interventions.

Standard obstetric practice dictates that Rh immune globulin must be administered within 72 hours after delivery to an unsensitized Rh-negative mother who delivers an Rh-positive infant. Timely administration within this 72-hour window neutralizes circulating Rh-positive fetal red blood cells before the maternal immune system can recognize foreign D antigens and produce maternal antibodies, preventing hemolytic disease of the fetus and newborn in subsequent pregnancies. Administering the dose within 24 hours after delivery is safe and acceptable if testing is complete, but it is not the maximum permitted clinical timeframe, as caregivers have up to 72 hours to complete testing and dosing. Waiting until within 7 days after delivery is incorrect because delaying administration beyond 72 hours dramatically increases the risk of maternal alloimmunization; although partial protection may still occur if given up to 28 days postpartum, 72 hours remains the established therapeutic standard. Thus, completing administration within 72 hours postpartum represents the evidence-based timeframe required to prevent maternal isoimmunization. Prompt identification of the infant blood type facilitates timely nursing administration.

A fetal spiral electrode is a small wire twisted into the epidermis of the fetal scalp or buttock. The puncture creates a portal of entry for maternal bloodborne and genital pathogens, so the electrode is avoided when the mother has HIV infection, active genital herpes, or hepatitis B or C, unless a clear indication outweighs the transmission risk. If the external tracing is hard to read, the nurse repositions the transducer, confirms the maternal pulse is not being recorded, and notifies the provider. Placement also requires ruptured membranes, adequate dilation, and a known presenting part, and it is avoided with placenta previa or a suspected fetal bleeding disorder. Rh-negative blood type with a negative antibody screen is not a contraindication; the electrode does not cause clinically significant fetomaternal hemorrhage, and Rh status is managed with newborn testing and Rh immune globulin when the newborn is Rh positive. A prior low transverse cesarean with a trial of labor is not a contraindication either; continuous monitoring is recommended for these patients, and the electrode attaches to the fetus, not to the uterine scar.

Leopold's first maneuver involves palpating the maternal uterine fundus while facing the patient to determine which fetal pole occupies the upper abdomen. A soft, irregular, non-ballottable mass indicates the fetal breech, whereas a firm, round, smooth, and freely movable mass indicates the fetal head. This assessment helps establish fetal lie (longitudinal versus transverse) and fetal presentation (cephalic versus breech). Palpating the bilateral uterine walls corresponds to the second maneuver, which identifies the location of the fetal back and small extremities to guide optimal placement of external fetal monitors. Palpating the lower uterine segment above the symphysis pubis area describes the third maneuver (Pawlik's grip) or fourth maneuver, which assess the presenting part, determine whether it is engaged in the maternal pelvis, and evaluate the degree of cephalic flexion.

For patients with gestational diabetes mellitus, the American College of Obstetricians and Gynecologists recommends target capillary blood glucose levels to prevent maternal and fetal complications such as macrosomia, neonatal hypoglycemia, and preeclampsia. The recommended glycemic target for 2-hour postprandial blood glucose measurements is maintained strictly below 120 mg/dL. The target value maintained strictly below 105 mg/dL is inaccurate because fasting and preprandial blood glucose levels are typically targeted below 95 mg/dL; 105 mg/dL was an older fasting threshold that is no longer accepted for optimal perinatal outcomes. A target maintained strictly below 140 mg/dL is the standard threshold for 1-hour postprandial measurements, not 2-hour measurements. Allowing glucose levels to remain up to 140 mg/dL at two hours postprandial reflects suboptimal control and is associated with increased risks of fetal hyperinsulinemia and excessive fetal somatic growth. Consistent monitoring ensuring levels remain below 120 mg/dL at two hours postprandial provides the best balance between preventing fetal overgrowth and avoiding maternal hypoglycemia.

Maternal hypotension is the most frequent acute adverse effect following the initiation of epidural or spinal analgesia in laboring women. It results from sympathetic blockade, which induces arterial and venous vasodilation, leading to pooling of blood in the lower extremities, decreased venous return, and reduced cardiac output. If uncorrected, this can quickly decrease uteroplacental perfusion and cause fetal bradycardia. Postdural puncture headache is an adverse effect that occurs only if the dura mater is unintentionally punctured during catheter placement, and its onset is typically delayed by 24 to 48 hours rather than appearing acutely. Systemic local anesthetic toxicity (LAST) is a rare, life-threatening complication resulting from direct intravascular injection or rapid systemic absorption, but it occurs far less frequently than maternal hypotension. Routine nursing management involves prophylactic fluid preloading, lateral uterine displacement, and prompt treatment with ephedrine or phenylephrine.

In a healthy, full-term neonate, the head circumference averages 33 to 35 centimeters and is approximately two centimeters larger than the chest circumference, which typically ranges from 30 to 33 centimeters. The occipitofrontal circumference reflects brain size and cranial development, whereas the chest is measured across the nipple line at end-expiration. Being equal to the measured chest circumference can occur in cases of significant cranial molding or caput succedaneum resolution, but it is not the typical baseline relationship at birth; equality usually develops between one and two years of age as thoracic dimensions expand. Being two centimeters smaller than chest circumference suggests pathologic abnormalities such as microcephaly or craniosynostosis and warrants further neurologic and genetic evaluation. Recognizing expected anthropometric ratios helps the nurse identify abnormal head growth patterns early.

Fetal vessels traversing internal os unsupported by placenta definitively defines vasa previa. In this condition, unprotected fetal blood vessels run through the fetal membranes across or adjacent to the internal cervical os, leaving them susceptible to tearing upon membrane rupture, which leads to rapid fetal exsanguination. Placental edge implanted within two centimeters of os is incorrect because this describes a low-lying placenta or marginal placenta previa, where placental tissue approaches the internal os but unsupported fetal vessels do not cross it. Umbilical cord inserting along the peripheral placental margin is incorrect because it describes a marginal cord insertion (battledore placenta), a benign cord variation that does not involve unsupported vessels running across the internal os. Vasa previa requires planned cesarean birth prior to membrane rupture.

According to the National Institute of Child Health and Human Development (NICHD) fetal monitoring guidelines, a variable deceleration is defined as a visually apparent, abrupt decrease in fetal heart rate below the baseline. The defining metric for an abrupt descent requires that the time from the onset of the deceleration to the nadir must be less than 30 seconds. The total decrease is at least 15 beats per minute lasting at least 15 seconds but less than two minutes. A descent where the time from deceleration onset to nadir is at least 30 seconds defines a gradual deceleration, which characterizes early or late decelerations rather than variable patterns. Describing a tracing where the total duration from deceleration onset to baseline recovery exceeds two minutes defines a prolonged deceleration, which represents an entirely distinct category of fetal heart rate perturbation. Variable decelerations are mediated by baroreceptor and chemoreceptor responses secondary to umbilical cord compression, and their hallmark characteristic remains this rapid, abrupt descent under 30 seconds.

Amniotic fluid embolism, also known as anaphylactoid syndrome of pregnancy, is an obstetric emergency triggered by the entry of amniotic fluid or fetal material into the maternal circulation. This triggers a catastrophic biphasic response characterized by sudden cardiorespiratory arrest, profound cyanosis, and severe consumptive coagulopathy manifesting as disseminated intravascular coagulation. Severe hypertension, generalized seizures, and hyperreflexia describe an eclamptic seizure rather than an amniotic fluid embolism; amniotic fluid embolism produces profound systemic hypotension and cardiovascular collapse rather than severe hypertension. Unilateral pleuritic pain, hemoptysis, and low-grade fever are characteristic findings of an isolated pulmonary thromboembolism, which does not typically produce the combined cardiovascular collapse and severe consumptive coagulopathy seen in amniotic fluid embolism. Immediate recognition and multidisciplinary resuscitation are vital to maternal survival.

Placental abruption is recognized as the single most common clinical etiology of acute disseminated intravascular coagulation in pregnant patients. The underlying pathophysiologic mechanism involves extensive retroplacental hemorrhage and decidual tissue disruption, which releases massive amounts of tissue factor (thromboplastin) directly into the maternal circulation. This triggers widespread extrinsic coagulation cascade activation, resulting in systemic microvascular thrombosis, consumption of platelets and fibrinogen, and rapid consumption coagulopathy. Therefore, acute occurrence of placental abruption is the correct answer. While anaphylactoid syndrome of pregnancy, also known as amniotic fluid embolism, is a devastating catastrophic cause of consumptive coagulopathy, it occurs far less frequently than placental abruption, making it a secondary overall cause rather than the most common. Similarly, retained nonviable intrauterine products, often termed retained dead fetus syndrome, can induce severe coagulopathy due to chronic thromboplastin leakage, but this process typically develops slowly over several weeks and accounts for a small fraction of clinical cases compared to the frequent occurrence of acute placental abruption.

The Bishop score is a standardized pre-induction scoring system utilized by perinatal clinicians to evaluate cervical readiness and predict the likelihood of successful vaginal birth following labor induction. The five specific clinical components evaluated in the Bishop scoring criteria are cervical dilation, cervical effacement, fetal station, cervical consistency, and cervical position. Each parameter receives a numerical score ranging from zero to two or three, generating a cumulative score between zero and thirteen. Identifying these five components allows the healthcare team to select appropriate ripening agents or proceed directly to oxytocin administration. Options that incorporate presentation, membrane status, pelvic shape, or uterine tone are incorrect because none of these variables are included in the traditional Bishop scoring rubric. Although fetal presentation and membrane status are critical factors in the comprehensive clinical assessment prior to induction, they do not contribute to the Bishop score. Similarly, clinical pelvimetry to determine pelvic shape and assessment of resting uterine tone reflect obstetric adequacy and myometrial activity rather than cervical favorability. Systematically documenting the five true Bishop parameters ensures accurate clinical communication.

Postpartum lochia represents the normal sloughing of the uterine decidual tissue and progresses through three distinct color and compositional stages during uterine involution. Lochia alba is the final stage, characterized by a creamy, yellowish-white discharge rich in leukocytes, decidual cells, epithelial cells, and cervical mucus. This stage starts at day ten and persists up to six weeks postpartum, reflecting ongoing cellular regeneration of the endometrium. The description that it starts at day three and persists up to two weeks corresponds instead to lochia serosa, which is a pinkish-brown, watery discharge containing serous exudate, erythrocytes, leukocytes, and cervical mucus that typically follows lochia rubra. The claim that it starts at day twenty-one and persists up to three months represents an abnormal and delayed timeline; persistent lochia beyond six to eight weeks postpartum warrants medical evaluation for subinvolution, retained placental fragments, or endometritis. Providing anticipatory guidance regarding the normal transitions from rubra to serosa to alba helps patients recognize normal healing and identify abnormal bleeding.

Umbilical cord blood gas analysis evaluates both incoming maternal-placental oxygenation via the umbilical vein and fetal tissue metabolic status via the umbilical arteries. Umbilical venous blood carries freshly oxygenated, low-carbon-dioxide blood from the placenta to the fetus, whereas umbilical arterial blood carries deoxygenated blood laden with carbon dioxide and metabolic end-products from fetal tissues back to the placenta. Consequently, the umbilical venous pH is physiologically 0.05 to 0.10 units higher than the umbilical arterial pH. A difference of 0.01 to 0.03 pH units is too narrow; when the difference between the two vessels is less than 0.02 to 0.03 pH units, it strongly suggests that the same vessel was inadvertently sampled twice rather than obtaining a true paired sample. Conversely, a difference of 0.15 to 0.20 pH units represents an excessively wide arteriovenous gradient, which may indicate acute severe umbilical cord occlusion where arterial clearance is blocked. Confirming a normal gradient of 0.05 to 0.10 pH units validates the sample accuracy and confirms proper sampling of both umbilical vessels.

5 to 10 mg administered over 2 minutes is the standard initial intravenous dose of hydralazine recommended for acute, severe maternal hypertension (systolic blood pressure of 160 mm Hg or higher, or diastolic blood pressure of 110 mm Hg or higher). Blood pressure must be remeasured in 20 minutes; if severe hypertension persists, a subsequent dose of 10 mg IV may be given. 10 to 20 mg administered as a rapid bolus is incorrect because rapid administration of a large initial bolus causes maternal hypotension, reflex tachycardia, and compromised uteroplacental perfusion, which jeopardizes fetal oxygenation. 20 to 40 mg infused over 15 minutes is incorrect because it reflects an excessive initial single dose that deviates from established obstetric hypertensive crisis algorithms. Proper dosing achieves safe, gradual vasodilation without triggering dangerous maternal or fetal decompensation.

The third stage of labor begins immediately after the complete expulsion of the fetus and ends with the delivery of the placenta and fetal membranes. Under normal physiological conditions and with active management of the third stage, the placenta typically detaches and expels within five to ten minutes of birth. A retained placenta is formally diagnosed when the organ fails to expel spontaneously or with controlled cord traction within thirty minutes after neonatal delivery. Exceeding thirty minutes substantially escalates the risk of severe postpartum hemorrhage, uterine atony, and endometritis, necessitating active clinical interventions such as manual extraction under analgesia or surgical curettage. In contrast, fifteen minutes after neonatal delivery represents an ongoing physiological third stage that does not yet meet diagnostic thresholds for retained tissue, though surveillance remains high. Forty-five minutes after neonatal delivery is excessively delayed; postponing intervention until this point inappropriately exposes the patient to an elevated risk of severe bleeding and hemodynamic instability.

The correct choice is baseline amplitude fluctuations that are visually undetectable. The National Institute of Child Health and Human Development (NICHD) fetal monitoring guidelines provide standardized, consensus-based nomenclature for interpreting electronic fetal heart rate patterns. Baseline variability is determined within a 10-minute window, excluding accelerations and decelerations, and represents the visually quantified peak-to-trough amplitude of baseline fluctuations. Absent variability is explicitly defined as an amplitude range that is visually undetectable from the baseline trace. In contrast, baseline amplitude fluctuations detectable up to five beats defines minimal variability, which describes an amplitude range visually detected but measuring five beats per minute or fewer. Baseline amplitude fluctuations between six and twenty-five beats defines moderate variability, which is the physiological hallmark of normal fetal acid-base balance and intact central nervous system oxygenation. Baseline amplitude fluctuations greater than twenty-five beats per minute represent marked variability. Understanding these specific numerical thresholds is essential for accurate categorization into Category I, II, or III fetal tracings.